Glycogen synthase kinase‐3 inhibitor AR‐A014418 suppresses pancreatic cancer cell growth via inhibition of GSK‐3‐mediated Notch1 expression

Publisher： John Wiley & Sons Inc

E-ISSN： 1477-2574|17|9|770-776

ISSN： 1365-182x

Source： HPB, Vol.17, Iss.9, 2015-09, pp. : 770-776

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3‐AR axis inhibition

By  

THE PROSTATE, Vol. 75, Iss. 13, 2015-09 ,pp. : 1341-1353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Erratum: Inhibition of nuclear factor κb activity by genistein is mediated via Notch‐1 signaling pathway in pancreatic cancer cells

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 134, Iss. 8, 2014-04 ,pp. : E3-E3

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of amyloid‐β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)‐3β

By  

NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol. 41, Iss. 4, 2015-06 ,pp. : 445-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Whether lithium inhibits glycogen synthase kinase (GSK)‐3β activity in vivo in humans is still an open question

By  

BIPOLAR DISORDERS (ELECTRONIC), Vol. 18, Iss. 5, 2016-08 ,pp. : 464-467

John Wiley & Sons Inc

Access to resources Recommend Favorite

Glycogen synthase kinase‐3 controls IL‐10 expression in CD4+ effector T‐cell subsets through epigenetic modification of the IL‐10 promoter

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 4, 2015-04 ,pp. : 1103-1115

John Wiley & Sons Inc

Access to resources Recommend Favorite